Posts by: Carolina Henriques

Carolina Henriques

Carolina holds a BSc in Anthropology and a MSc in Urban Studies., and brings her interdisciplinary skills to her writing on a range of different topics in science, research and advocacy news.

July 12, 2017July 12, 2017

High Sugar Intake While Pregnant May Increase Child’s Risk of Developing Allergic Asthma, Study Finds

Asthma, News

Women who consume a large amount of sugar when they’re pregnant may find their children at an increased risk for allergy and allergic asthma, according to researchers from Queen Mary University ... Read more

July 11, 2017July 11, 2017

Trial Underway in Rare Lung Disease That Can Cause PF and Targets People from Puerto Rico

News

Vanderbilt University researchers are sponsoring the first major study of a rare lung disease that disproportionately affects people from Puerto Rico and can cause pulmonary fibrosis. Called Hermansky-Pudlak syndrome (HPS), the ... Read more

July 7, 2017July 7, 2017

Vectura Signs Agreement with Sandoz to Develop Generic Combination Therapy for Asthma and COPD in the U.S.

News

A generic version of an existing inhaled combination therapy for asthma and chronic obstructive pulmonary disease (COPD) will be developed in the United States under an agreement between Vectura Group subsidiary Jagotec ... Read more

June 28, 2017June 28, 2017

Childhood Asthma Found to Increase Risk of Heart Thickening in Adulthood

Asthma, News

Researchers have found an association between childhood asthma and a greater risk of thickening of the left ventricle in the heart, particularly in patients with prehypertension and hypertension. Thickening of the ... Read more

June 5, 2017June 5, 2017

Irish Health Service Covers Vertex’s Cystic Fibrosis Therapies Orkambi and Kalydeco

Cystic Fibrosis, News

Hundreds of cystic fibrosis patients in Ireland have obtained national health service coverage for the Vertex Pharmaceuticals therapies Orkambi (lumacaftor/ivacaftor) and Kalydeco (ivacaftor). The agreement between the Irish Health Service Executive and Vertex ... Read more

May 16, 2017May 16, 2017

Genoa Pharmaceuticals Secures $62 Million in Funding to Evaluate Aerodone in IPF Treatment

Idiopathic Pulmonary Fibrosis, News

Genoa Pharmaceuticals has completed $62 million in a Series A financing round that secures funds for a Phase 2 clinical trial to evaluate Aerodone (inhaled pirfenidone) in treating diopathic pulmonary fibrosis ... Read more

May 12, 2017May 12, 2017

Genomic Classifiers Shown to Improve Diagnosis of Lung Cancer and IPF, Veracyte Says

Idiopathic Pulmonary Fibrosis, Lung Cancer, News

Multiple studies’ data support the use of Veracyte’s genomic classifiers to improve the diagnosis of lung cancer and idiopathic pulmonary fibrosis (IPF), the company reports. The data will be presented ... Read more

May 3, 2017May 3, 2017

Three Lakes Partners and MATTER Announce $1M IPF Catalyst Challenge

Idiopathic Pulmonary Fibrosis, News

Three Lakes Partners and MATTER announced a $1 million IPF Catalyst Challenge to engage innovators, entrepreneurs and researchers to find solutions for idiopathic pulmonary fibrosis (IPF) patients’ greatest need – ... Read more

April 24, 2017April 24, 2017

British Researchers Develop One-Hour Flu and Viral Infections Test

Asthma, COPD, News

British researchers have developed an innovative approach to using a swab test to diagnose flu and other viral infections in patients with respiratory conditions, resulting in shorter courses of antibiotics ... Read more

April 20, 2017April 20, 2017

Boehringer Ingelheim Phase 3 Trial Evaluates Ofev in Patients with Progressive Fibrosing Interstitial Lung Disease

Idiopathic Pulmonary Fibrosis, News

Boehringer Ingelheim Pharmaceuticals has enrolled the first patient in its progressive fibrosing interstitial lung disease (PF-ILD) clinical trial, which will investigate the effectiveness and safety of Ofev (nintedanib) in a ... Read more